Celularity (CELU) Assets (2018 - 2025)
Celularity (CELU) posted quarterly Assets of $336000.0 for Q4 2025, down 99.75% year-over-year from $132.7 million in Q4 2024, and down 99.71% quarter-over-quarter from $114.2 million in Q3 2025.
Celularity (CELU) Assets (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Assets for 8 consecutive years, with $336000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets fell 99.75% year-over-year to $336000.0; the TTM figure through Dec 2025 stood at $336000.0 (down 99.75% YoY), while the FY2025 annual figure was $336000.0, down 99.75% from the prior year.
- Assets fell to $336000.0 in Q4 2025 per CELU's latest filing, from $114.2 million in the prior quarter.
- Across five years, Assets topped out at $448.3 million in Q3 2021 and bottomed at $336000.0 in Q4 2025.
- Historically, Assets has averaged $239.9 million across 5 years, with a median of $150.5 million in 2023.
- Annual changes were most pronounced in 2022 — Assets soared 234.33% — and 2025, when it slumped 99.75%.
- Celularity's Assets stood at $414.1 million in 2021, then dropped by 3.15% to $401.1 million in 2022, then tumbled by 64.12% to $143.9 million in 2023, then declined by 7.79% to $132.7 million in 2024, then plunged by 99.75% to $336000.0 in 2025.
- Business Quant data shows CELU's Assets at $336000.0 in Q4 2025, $114.2 million in Q3 2025, and $120.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Celularity | 20.90 Mn | 14.72 Mn | -3.27 Mn | 336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,000.00 |
| Sep 30, 2025 | 114.24 Mn |
| Jun 30, 2025 | 120.28 Mn |
| Mar 31, 2025 | 128.88 Mn |
| Dec 31, 2024 | 132.68 Mn |
| Sep 30, 2024 | 128.84 Mn |
| Jun 30, 2024 | 135.49 Mn |
| Mar 31, 2024 | 143.82 Mn |
| Dec 31, 2023 | 143.89 Mn |
| Sep 30, 2023 | 157.19 Mn |
| Jun 30, 2023 | 246.42 Mn |
| Mar 31, 2023 | 362.42 Mn |
| Dec 31, 2022 | 401.07 Mn |
| Sep 30, 2022 | 437.12 Mn |
| Jun 30, 2022 | 429.34 Mn |
| Mar 31, 2022 | 434.20 Mn |
| Dec 31, 2021 | 414.13 Mn |
| Sep 30, 2021 | 448.29 Mn |
| Jun 30, 2021 | 128.42 Mn |
| Mar 31, 2021 | 291.93 Mn |